|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.146 SEK | -1.01% |
|
-0.92% | -48.72% |
| 06-11 | Cantargia to host expert meeting on nadunolimab in pancreatic cancer | FW |
| 06-10 | Cantargia Doses First Patient in Phase 2 Lung Cancer Prevention Trial | MT |
| Market Cap | 534M 55.05M 48.18M 44.48M 41.49M 78.17M 5.2B 79.57M 207M 2.57B 207M 202M 8.95B | P/E 2026 * |
-3.3x | P/E 2027 * | -2.94x |
|---|---|---|---|---|---|
| Enterprise Value | 534M 55.05M 48.18M 44.48M 41.49M 78.17M 5.2B 79.57M 207M 2.57B 207M 202M 8.95B | EV / Sales 2026 * |
508x | EV / Sales 2027 * | 13.9x |
| Free-Float |
83.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cantargia AB
| 1 day | -1.01% | ||
| 1 week | -0.92% | ||
| 1 month | -1.56% | ||
| 3 months | -47.47% | ||
| 6 months | -48.72% | ||
| Current year | -48.72% |
| 1 week | 2.07 |  | 2.3 |
| 1 month | 1.86 | | 2.3 |
| Current year | 1.86 | | 6.59 |
| 1 year | 1.13 | | 6.59 |
| 3 years | 1 | | 6.59 |
| 5 years | 1 | | 27.92 |
| 10 years | 1 | | 71.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 2025-08-31 | |
Patrik Renblad
DFI | Director of Finance/CFO | 56 | 2023-06-14 |
Wolfram Dempke
CTO | Chief Tech/Sci/R&D Officer | - | 2025-10-01 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2015-12-31 | |
| Director/Board Member | 55 | 2017-12-31 | |
Flavia Borellini
BRD | Director/Board Member | 64 | 2020-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-24 | Buy | 4,444 | 0.0018% | |||
| 06-22 | Buy | Executive/Senior Manager | 16,154 | 0.0065% | ||
| 06-22 | Fiscal year | Executive/Senior Manager | -72,693 | 0.0292% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | -0.92% | +58.96% | -47.40% | 55.41M | |
| +3.31% | -0.20% | +72.71% | +128.31% | 55.78B | |
| -1.32% | +17.12% | +79.02% | +99.82% | 55.66B | |
| -1.28% | +2.68% | -12.60% | -13.79% | 23.84B | |
| +1.79% | +4.38% | +5.94% | +405.31% | 22.7B | |
| -1.93% | +11.11% | +34.89% | -7.86% | 18.5B | |
| +4.45% | +5.06% | +36.50% | -30.43% | 16.12B | |
| +0.24% | +5.98% | +23.45% | +184.72% | 13.64B | |
| +0.14% | +9.60% | +33.31% | - | 12.95B | |
| +1.83% | +4.58% | +77.42% | +132.45% | 12.16B | |
| Average | +0.62% | +5.02% | +40.96% | +94.57% | 23.14B | |
| Weighted average by Cap. | +0.80% | +4.93% | +48.48% | +114.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.05M 108K 94.83K 87.54K 81.65K 154K 10.24M 157K 408K 5.05M 407K 398K 17.61M | 38.35M 3.96M 3.46M 3.2M 2.98M 5.62M 374M 5.72M 14.89M 185M 14.87M 14.53M 643M |
| Net income | -179M -18.49M -16.19M -14.94M -13.94M -26.26M -1.75B -26.73M -69.59M -863M -69.48M -67.93M -3.01B | -180M -18.54M -16.22M -14.98M -13.97M -26.32M -1.75B -26.79M -69.74M -865M -69.64M -68.08M -3.01B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-30 | SEK 2.146 | -1.01% | 250,742 |
| 26-06-29 | SEK 2.168 | +1.03% | 405,073 |
| 26-06-26 | SEK 2.146 | +0.56% | 454,241 |
| 26-06-25 | SEK 2.134 | +4.10% | 748,044 |
| 26-06-24 | SEK 2.050 | -5.36% | 2,141,689 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CANTA Stock
Select your edition
All financial news and data tailored to specific country editions
